New patent (CN110656087B) granted Jan 2022 for MANF in Umbilical Cord Mesenchymal Stem Cells for treating Spinal Cord Injury that cites our MANF application.

Filed by: Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China following the publishing of this research: https://pubmed.ncbi.nlm.nih.gov/29797541/#affiliation-1